Andere talen Protara Therapeutics, Inc.

Aandelen

TARA

US74365U1079

Geschatte realtime Cboe BZX Andere beurzen 17:18:00 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,935 ^USD	+0,86%		-4,52%	+57,86%

02/05	Protara Therapeutics, Inc. rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
05/04	Protara Therapeutics, Inc. kondigt een overeenkomst aan met de FDA over het registratiepad voor IV Choline Chloride bij patiënten die afhankelijk zijn van parenterale voeding	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Protara Therapeutics: Q1 Earnings Snapshot	02/05
Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update	02/05
Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors	30/04
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing	05/04
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics, Inc Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition	05/04
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC	05/04
Protara Therapeutics, Inc. Announces Resignation of Jathin Bandari as Chief Medical Officer, Effective April 11, 2024	18/03
Protara Therapeutics: Q4 Earnings Snapshot	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Protara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	13/03
Proteon Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
North American Morning Briefing : Stock Futures -2-	13/03
Top Premarket Gainers	12/03
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02
Top Premarket Decliners	12/02
Protara Therapeutics to Participate in Upcoming Investor Conferences	31/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Protara Therapeutics, Inc.

Aandelen

TARA

US74365U1079

Andere talen

Filters